1. Home
  2. RYTM vs AUB Comparison

RYTM vs AUB Comparison

Compare RYTM & AUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • AUB
  • Stock Information
  • Founded
  • RYTM 2008
  • AUB 1902
  • Country
  • RYTM United States
  • AUB United States
  • Employees
  • RYTM N/A
  • AUB N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • AUB Major Banks
  • Sector
  • RYTM Health Care
  • AUB Finance
  • Exchange
  • RYTM Nasdaq
  • AUB Nasdaq
  • Market Cap
  • RYTM 4.3B
  • AUB 3.5B
  • IPO Year
  • RYTM 2017
  • AUB N/A
  • Fundamental
  • Price
  • RYTM $65.25
  • AUB $32.72
  • Analyst Decision
  • RYTM Strong Buy
  • AUB Buy
  • Analyst Count
  • RYTM 12
  • AUB 6
  • Target Price
  • RYTM $77.50
  • AUB $39.17
  • AVG Volume (30 Days)
  • RYTM 585.3K
  • AUB 1.9M
  • Earning Date
  • RYTM 08-05-2025
  • AUB 07-24-2025
  • Dividend Yield
  • RYTM N/A
  • AUB 4.35%
  • EPS Growth
  • RYTM N/A
  • AUB N/A
  • EPS
  • RYTM N/A
  • AUB 2.15
  • Revenue
  • RYTM $136,863,000.00
  • AUB $797,879,000.00
  • Revenue This Year
  • RYTM $37.56
  • AUB $76.85
  • Revenue Next Year
  • RYTM $74.99
  • AUB $15.84
  • P/E Ratio
  • RYTM N/A
  • AUB $14.54
  • Revenue Growth
  • RYTM 48.88
  • AUB 16.62
  • 52 Week Low
  • RYTM $40.46
  • AUB $22.85
  • 52 Week High
  • RYTM $69.89
  • AUB $44.54
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 53.08
  • AUB 57.17
  • Support Level
  • RYTM $60.80
  • AUB $30.55
  • Resistance Level
  • RYTM $64.00
  • AUB $31.82
  • Average True Range (ATR)
  • RYTM 1.96
  • AUB 0.66
  • MACD
  • RYTM -0.13
  • AUB 0.01
  • Stochastic Oscillator
  • RYTM 44.48
  • AUB 57.61

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About AUB Atlantic Union Bankshares Corporation

Atlantic Union Bankshares Corp is a financial holding company and a bank holding company. Through its community bank subsidiary, the company provides financial services, including banking, trust, and wealth management. The bank is a full-service community bank offering consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from Wholesale Banking.

Share on Social Networks: